These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 22412904)
21. Liver disease-associated keratin 8 and 18 mutations modulate keratin acetylation and methylation. Jang KH; Yoon HN; Lee J; Yi H; Park SY; Lee SY; Lim Y; Lee HJ; Cho JW; Paik YK; Hancock WS; Ku NO FASEB J; 2019 Aug; 33(8):9030-9043. PubMed ID: 31199680 [TBL] [Abstract][Full Text] [Related]
22. Absence of keratins 8 and 18 in rodent epithelial cell lines associates with keratin gene mutation and DNA methylation: Cell line selective effects on cell invasion. Kwan R; Looi KS; Omary MB Exp Cell Res; 2015 Jul; 335(1):12-22. PubMed ID: 25882495 [TBL] [Abstract][Full Text] [Related]
24. Novel insights into changes in biochemical properties of keratins 8 and 18 in griseofulvin-induced toxic liver injury. Fortier AM; Riopel K; Désaulniers M; Cadrin M Exp Mol Pathol; 2010 Oct; 89(2):117-25. PubMed ID: 20643122 [TBL] [Abstract][Full Text] [Related]
25. Mutation of caspase-digestion sites in keratin 18 interferes with filament reorganization, and predisposes to hepatocyte necrosis and loss of membrane integrity. Weerasinghe SV; Ku NO; Altshuler PJ; Kwan R; Omary MB J Cell Sci; 2014 Apr; 127(Pt 7):1464-75. PubMed ID: 24463813 [TBL] [Abstract][Full Text] [Related]
26. Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury. Tao GZ; Toivola DM; Zhong B; Michie SA; Resurreccion EZ; Tamai Y; Taketo MM; Omary MB J Cell Sci; 2003 Nov; 116(Pt 22):4629-38. PubMed ID: 14576356 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis. Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216 [TBL] [Abstract][Full Text] [Related]
28. Keratin impact on PKCδ- and ASMase-mediated regulation of hepatocyte lipid raft size - implication for FasR-associated apoptosis. Gilbert S; Loranger A; Omary MB; Marceau N J Cell Sci; 2016 Sep; 129(17):3262-73. PubMed ID: 27422101 [TBL] [Abstract][Full Text] [Related]
29. Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury. Ku NO; Soetikno RM; Omary MB Hepatology; 2003 May; 37(5):1006-14. PubMed ID: 12717381 [TBL] [Abstract][Full Text] [Related]
30. Intestinal cell barrier function in vitro is severely compromised by keratin 8 and 18 mutations identified in patients with inflammatory bowel disease. Zupancic T; Stojan J; Lane EB; Komel R; Bedina-Zavec A; Liovic M PLoS One; 2014; 9(6):e99398. PubMed ID: 24915158 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis. Zamin I; Mattos AA; Mattos AZ; Migon E; Bica C; Alexandre CO Arq Gastroenterol; 2006; 43(3):224-8. PubMed ID: 17160239 [TBL] [Abstract][Full Text] [Related]
32. Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation. Snider NT; Weerasinghe SV; Iñiguez-Lluhí JA; Herrmann H; Omary MB J Biol Chem; 2011 Jan; 286(3):2273-84. PubMed ID: 21062750 [TBL] [Abstract][Full Text] [Related]
33. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344 [TBL] [Abstract][Full Text] [Related]
34. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases. Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603 [TBL] [Abstract][Full Text] [Related]
35. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis. Duarte TL; Caldas C; Santos AG; Silva-Gomes S; Santos-Gonçalves A; Martins MJ; Porto G; Lopes JM Redox Biol; 2017 Apr; 11():157-169. PubMed ID: 27936457 [TBL] [Abstract][Full Text] [Related]
36. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes. Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997 [TBL] [Abstract][Full Text] [Related]
37. Could iron deposits in hepatocytes serve as a prognostic marker of HFE gene mutations? Sikorska K; Stalke P; Jaskiewicz K; Romanowski T; Bielawski KP Hepatogastroenterology; 2008; 55(84):1024-8. PubMed ID: 18705322 [TBL] [Abstract][Full Text] [Related]
38. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations. Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249 [TBL] [Abstract][Full Text] [Related]